Rhythm Pharmaceuticals (RYTM) has an average rating of buy and mean price target of $138.59, according to analysts polled by FactSet.
What else is happening in Research?
Research
BofA Securities Initiates Bandwidth With Neutral Rating, $60 Price Target
Bandwidth (BAND) has an average rating of overweight and mean price target of $68.60, according to analysts polled by FactSet.Price: $49.63, Change: $-0.45, Percent Change: -0.90%
$BAND
Research
Cardinal Energy Upgraded at Raymond James, Advantage Energy and Birchcliff Energy Downgraded
Raymond James adjusted its ratings on three Canadian energy stocks on Wednesday.Analyst Michael Barth upgraded Cardinal Energy Ltd. (CJ.TO) to outperform from market perform, and raised his price target to CA$15 from CA$12.Barth downgraded Advantage Energy Ltd. (AAV.TO) to market perform from outperform, and reduced his target to CA$13 to CA$14.The analyst downgraded Birchcliff Energy Ltd. (BIR.TO) to market perform from outperform, and lowered his price target to CA$8 from CA$8.50."While we continue to see longer-term value in both AAV and BIR, tactically we think continued positioning in oil-weighted names makes sense today," Barth said in a note to clients.
$AAV.TO$BIR.TO$CJ.TO
Research
AlphaValue/Baader Europe Upgrades Rentokil Initial to Add, Trims PT
AlphaValue/Baader Europe on Wednesday upgraded pest control company Rentokil Initial (RTO.L) to add from reduce and trimmed its price target to 3.75 pounds sterling from 3.76 pounds.
$RTO.L